BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2010
View Archived Issues
Schering Plough receives approval for Temodal in Japan
Read More
Natural product IDN-5706 has beneficial effects in mouse model of AD
Read More
Curemark initiates enrollment into phase III clinical trials of CM-AT in the U.S.
Read More
EMEA initiates review of Amsterdam MolecularTherapeutics' MAA for Glybera in LPLD
Read More
Dynavax Technologies reports phase Ib data on SD-101 in chronic hepatitis C
Read More
INSYS Therapeutics completes efficacy trial of fentanyl sublingual spray
Read More
Shionogi launches peramivir in Japan
Read More
Envoy Therapeutics and Merck & Co. enter into diabetes and obesity collaboration
Read More
Romiplostim appears to be safe in MDS patients with thrombocytopenia
Read More
Penwest enters into fourth research and development agreement with Otsuka
Read More
Novel modulator of mitochondrial membrane potential shows antidiabetic effects in mice
Read More
Preclinical activity of novel mitotic kinesin inhibitor supports clinical evaluation in cancer
Read More
FDA approves Novo Nordisk's Victoza for certain adults with type 2 diabetes
Read More
Ambrilia discloses HIV integrase inhibitors for the prevention and treatment of AIDS
Read More
U.S. Army claims BoNT/A LC inhibitors for the treatment of C. botulinum infection
Read More
Telik initiates phase I trial of ezatiostat in patients with myelodysplastic syndrome
Read More
Bayer Schering describes novel adenosine A1 agonists for the treatment of CAD
Read More
Concert presents alpha2-adrenoceptor agonists for motor function disorders
Read More
PI3K and mTOR inhibitors in early development at Wyeth
Read More
Roche identifies novel tachykinin NK3 receptor antagonists as antipsychotics
Read More
New protein kinase inhibitors for the treatment of cancer discovered at Plexxikon
Read More
Prometheus Laboratories acquires exclusive rights to Proleukin in the U.S.
Read More
Amgen reports results from fourth quarter of 2009
Read More
China Aoxing completes phase III registration study of tilidine for moderate to severe pain
Read More
FDA reschedules review of NDA for Theratechnologies' tesamorelin
Read More
Dainippon obtains Japanese approval for additional indication for Meropen
Read More
